Your guide to commodities, currencies, crypto, and alternative markets.
Menu
Commodities Currencies Crypto Analyze News Calendar
Markets IndexesShares Bonds Holidays Emerging Markets ↗
Countries United States United Kingdom Euro Area Australia Canada Japan China Brazil Russia India More Countries
Indicators Interest Rate Inflation Rate Unemployment Rate GDP Growth GDP per Capita Current Account Government Debt More Indicators
Forecasts CountriesIndicators
Learn & Tools Learn Ask the Data Screener AI Agents API
About About us Disclaimer
Members
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language

Abbott Laboratories Price — Chart — Historical Data

116.67 0.0300 (0.03%) ABT

Share price, delayed as of Aug 25, 11:17 UTC Source: Financial Modeling Prep (delayed)

2025-07-152026-08-24
%ChgWeeklyMonthlyYTDYoY
Abbott Laboratories 0.03% 3.54% 13.21% -6.06% -11.53%

Latest Abbott Laboratories News

Gateway Wealth Partners LLC Sells 15,431 Shares of Abbott Laboratories $ABT ↗ Gateway Wealth Partners LLC lessened its stake in shares of Abbott Laboratories (NYSE: ABT) by 64.3% during the undefined quarter, according to its… Defense World · Aug 25, 04:09 UTC Choreo LLC Sells 4,580 Shares of Abbott Laboratories $ABT ↗ Choreo LLC cut its position in Abbott Laboratories (NYSE: ABT) by 4.4% during the second quarter, according to its most recent 13F filing with the… Defense World · Aug 25, 04:09 UTC Abbott Laboratories $ABT Shares Bought by Golden Reserve Retirement LLC ↗ Golden Reserve Retirement LLC grew its holdings in Abbott Laboratories (NYSE: ABT) by 155.2% in the undefined quarter, according to the company in… Defense World · Aug 25, 04:09 UTC Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗ AbbVie and Abbott stand out as strong healthcare investments because they combine established businesses with long-term growth opportunities. Fool - Investing News · Aug 24, 10:15 UTC ABT DCF Analysis: Intrinsic Value $94 vs Price $117 ↗ On August 24, 2026, we delve into the DCF analysis for Abbott Laboratories (ABT), a company currently facing a mixed price performance backdrop. Over… GuruFocus · Aug 24, 07:25 UTC The debt-fueled AI build-out may already be too big to fail ↗ The Federal Reserve’s pandemic corporate credit facilities have capped downside risks and remain part of its tool kit, says BofA Global MarketWatch · Aug 25, 11:12 UTC

Related

RelatedPrice%Chg
AbbVie Inc. 264.52 -0.17%
Amgen Inc. 443.84 1.03%
Cigna Corporation 280.45 1.06%
Danaher Corporation 215.20 -1.67%
Elevance Health Inc. 402.63 0.52%
Eli Lilly and Company 1,247.9 -0.60%
Gilead Sciences, Inc. 146.74 0.42%
Intuitive Surgical, Inc. 373.57 -1.38%

Business

Corporate ProfitsIndustrial Production YoY

Consumer

Consumer SentimentPersonal Savings RateRetail Sales MoM

GDP

GDPGDP Annual Growth RateGDP Growth RateGDP per Capita

Government

Government Debt to GDPGovernment Net Lending/Borrowing

Housing

Building PermitsHousing Starts

Labour

Initial Jobless ClaimsNon Farm PayrollsPopulationUnemployment Rate

Money

Foreign Exchange ReservesInterest RateLending Interest Rate

Prices

Core Inflation RateCore PCE InflationInflation RateInflation Rate MoM

Trade

Current Account to GDPExportsExternal Balance (Goods & Services)Imports